FuJae Partners advises Veranex on acquisition of Worrell
On December 7, 2021, Veranex announced that it entered into a binding agreement to acquire Worrell, a global design firm specializing in healthcare innovation and strategy.
Financial terms of the transaction were not disclosed. The transaction has been closed in December 2021, after finishing customary closing conditions.
“The addition of Worrell strengthens Veranex’s offerings as the leading global provider in the medical device and biotech space.” said Veranex Executive Chairman Patrick Donnelly.
FuJae Partners, together with its alliance firm McGuireWoods, advised Veranex on this acquisition deal in connection with the China entity and elements of this acquisition transaction.